Sort
10,766 grants matching “checkpoint inhibitor”
Understanding how the interaction between Lag3 deficiency and hypercholesterolemia impact anti-tumor immunity and cardiovascular disease in a melanoma model
$147,783Annabelle Rodriguez · University Of Connecticut Sch Of Med/Dnt · R21 · FY2024 · CA
HDAC6-Selective Inhibitors for Pancreatic Cancer Treatment
$147,605Werner Tueckmantel · Psychogenics, Inc. · R43 · FY2010 · CA
Mechanisms of Immune-mediated Tumor Cell Destruction
$147,600Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Role of T Regulatory Cell Suppression in Autoimmunity and Cancer
$147,518Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Integrating Spatial Omics and Drug Imaging to Dissect the Role of Pancreatic Tumor Microenvironment in Drug Resistance
$147,262Guolan Lu · Stanford University · K99 · FY2022 · CA
Integrating Spatial Omics and Drug Imaging to Dissect the Role of Pancreatic Tumor Microenvironment in Drug Resistance
$147,262Guolan Lu · Stanford University · K99 · FY2023 · CA
Data-driven Patient-Specific Agent Based Models of Metastatic Melanoma for Immunotherapy Response Prediction
$147,236James R. Heath · Institute For Systems Biology · U54 · FY2023 · CA
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
$146,757Goldy C George · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Project 2: Lung cancer screening Awareness Targeted and Tailored to Increase sCrEening (LATTICE)
$146,725Brian M. Rivers · Morehouse School Of Medicine · U54 · FY2025 · CA
Chemoenzymatic glycan editing for deciphering biological functions of glycans
$146,126Peng Wu · Scripps Research Institute, The · R35 · FY2023 · GM
The Spindle Checkpoint as a Target for Cancer
$145,500University Of Oklahoma Hlth Sciences Ctr · R21 · FY2002 · CA
A Chemical Biology Approach for Discovery of HDAC Inhibitors
$145,475Taro Amagata · San Francisco State University · SC2 · FY2010 · GM
G2 Role For Cdk2 in Human Cells
$145,350Gregory H. Enders · Fox Chase Cancer Center · R01 · FY2006 · GM
Tumor Immunology
$145,304Antoni Ribas · University Of California Los Angeles · P30 · FY2021 · CA
Tumor Immunology
$145,304Antoni Ribas · University Of California Los Angeles · P30 · FY2023 · CA
Tumor Immunology
$145,304Antoni Ribas · University Of California Los Angeles · P30 · FY2022 · CA
Tumor Immunology
$145,300Antoni Ribas · University Of California Los Angeles · P30 · FY2024 · CA
Mechanisms of liver metastasis and associated resistance to immunotherapy
$144,895Benjamin Izar · Columbia University Health Sciences · R37 · FY2023 · CA
Exosomes as carriers of cancer therapeutics
$144,805Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA
Software for Predicting Liver Injury from Biologics Drug Candidates Using Data from a Human Liver Microphysiology System
$144,614Brett Alyn Howell · Simulations Plus, Inc. · R43 · FY2021 · TR
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$144,537James R. Heath · Institute For Systems Biology · U54 · FY2025 · CA
Targeting PARP Proteins in electronic cigarettes-induced cardiac dysfunction
$144,500Jorge Espinoza-Derout · Charles R. Drew University Of Med & Sci · R16 · FY2025 · GM
Targeting PARP Proteins in electronic cigarettes-induced cardiac dysfunction
$144,500Jorge Espinoza-Derout · Charles R. Drew University Of Med & Sci · R16 · FY2024 · GM
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$144,181Venkataswarup Tiriveedhi · Tennessee State University · U54 · FY2019 · CA
Parameters that determine cell fate during mitotic arrest
$143,997Charles B Shuster · New Mexico State University Las Cruces · R16 · FY2025 · GM